4,499 followers
@dean_fennell discussing evidence for #IO efficacy in #meso https://t.co/MNZhVZWeRV #cosa18
@dean_fennell discussing evidence for #IO efficacy in #meso https://t.co/MNZhVZWeRV #cosa18
And that durable responses to a PD-1 inhibitor had been observed despite this low mutation burden https://t.co/HhTxy9RYrn
RT @jsoriamd: PD1 Ab have clear activity in mesothelioma. Why a registrational phase III trial is not ongoing? @TheLancetOncol https://t.…
RT @jsoriamd: PD1 Ab have clear activity in mesothelioma. Why a registrational phase III trial is not ongoing? @TheLancetOncol https://t.…